|230.00|| -1.45 / -0.63%|
C.R. Bard, Inc. designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. It sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The company's products include vascular, urology, oncology and surgical specialty products. The vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. The urology products include basic drainage products, continence products and urological specialty products. The oncology products cover a wide range of devices used in the treatment and management of various cancers and other diseases and disorders. The surgical specialties products include implanted patches and fixation systems for hernia and other soft tissue repairs in addition to hemostats and surgical sealants. C. R. Bard was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.
|Tim M. Ring||Chairman & Chief Executive Officer|
|John H. Weiland||President, Chief Operating Officer & Director|
|Christopher S. Holland||Chief Financial Officer & Senior Vice President|
|John A. DeFord||Senior VP-Science, Technology & Clinical Affairs|
|Patricia G. Christian||VP-Quality, Regulatory & Medical Affairs|